---
title: "Zhongtai Securities: Maintain Wolwo Pharma \"Buy\" rating, steady revenue growth, core products continue to expand"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/243243209.md"
description: "Zhongtai Securities maintains a \"Buy\" rating for Wolwo Pharma, expecting a net profit attributable to the parent company of 318 million yuan in 2024, a year-on-year increase of 2.46%. The net profit attributable to the parent company for the first quarter of 2025 is expected to be 74 million yuan, a year-on-year decrease of 3.71%. The company's revenue growth is steady, core products continue to increase in volume, market share exceeds 80%, and the sales of Artemisia annua powder drops continue to grow, with the product line constantly expanding"
datetime: "2025-06-05T09:33:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/243243209.md)
  - [en](https://longbridge.com/en/news/243243209.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/243243209.md)
---

# Zhongtai Securities: Maintain Wolwo Pharma "Buy" rating, steady revenue growth, core products continue to expand

Zhongtai Securities research report points out that Wolwo Pharma's net profit attributable to the parent company in 2024 is expected to be 318 million yuan, a year-on-year increase of 2.46%; the net profit attributable to the parent company in Q1 2025 is expected to be 74 million yuan, a year-on-year decrease of 3.71%. The performance meets expectations, with steady revenue growth, core products continuing to expand, and the point injection product matrix continuously widening. Considering the large population suffering from allergic diseases in China and the significant market space for desensitization, the company is a leading enterprise with a market share exceeding 80% in the domestic market. The artemisia annua powder drops continue to expand, and the pipeline is constantly broadening, maintaining an "overweight" rating

### Related Stocks

- [300357.CN](https://longbridge.com/en/quote/300357.CN.md)
- [600918.CN](https://longbridge.com/en/quote/600918.CN.md)

## Related News & Research

- [PRECIOUS-Treasury yields, dollar weigh on gold amid inflation concerns](https://longbridge.com/en/news/286929968.md)
- [PTA-DD: Warimpex Finanz- und Beteiligungs AG: Correction of a Managers' transactions announcement according to article 19 MAR from 19.05.2026](https://longbridge.com/en/news/287058272.md)
- [Phase 3-ready cancer biotech Parabilis Medicines files for a $100 million IPO](https://longbridge.com/en/news/286972125.md)
- [Motiva Port Arthur refinery reports crude oil release after pipe issues](https://longbridge.com/en/news/286971029.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)